Terms: = Bone cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Clinical Outcome
5 results:
1. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract] [Full Text] [Related]
2. Lenalidomide for the treatment of mantle cell lymphoma.
Morabito F; Skafi M; Recchia AG; Kashkeesh A; Hindiyeh M; Sabatleen A; Morabito L; Alijanazreh H; Hamamreh Y; Gentile M
Expert Opin Pharmacother; 2019 Apr; 20(5):487-494. PubMed ID: 30608891
[TBL] [Abstract] [Full Text] [Related]
3. clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy.
He H; Cheng L; Weiss LM; Chu PG
Leuk Lymphoma; 2007 Oct; 48(10):1976-80. PubMed ID: 17917966
[TBL] [Abstract] [Full Text] [Related]
4. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
Majlis A; Pugh WC; Rodriguez MA; Benedict WF; Cabanillas F
J Clin Oncol; 1997 Apr; 15(4):1664-71. PubMed ID: 9193367
[TBL] [Abstract] [Full Text] [Related]
5. Mantle cell lymphomas.
Rodriguez MA; Pugh WC
Cancer Treat Res; 1996; 85():41-50. PubMed ID: 9043774
[TBL] [Abstract] [Full Text] [Related]
